Overview

The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease

Status:
Completed

Trial end date:
2008-12-01

Target enrollment:

Participant gender:

Summary

This study attempts to differentiate the clinical responses of Choline Acetyltransferase and Apolipoprotein Epsilon gene polymorphism to donepezil in Alzheimer's Disease patients.

Phase:

Phase 4

Details

Lead Sponsor:

Eisai Korea Inc.

Treatments:

Choline
Donepezil